Our Partners
next generation therapy for Endometriosis
At FORAVISET, we have pioneered a breakthrough in endometriosis treatment with Raviset®, eliminating the need for hormonal therapies. By addressing the root causes of pain and inflammation, Raviset® offers a safer, more effective solution for millions of women, poised to deliver a transformative impact on women's health globally.
Join the Movement to Redefine Women’s Health
Investment and Partnership Opportunities Available
FORAVISET is leading a revolution in women's health, particularly in the realm of endometriosis, and we want to connect with you. Whether you’re an investor, a potential partner, a patient interested in our Raviset® trials, or someone eager to learn more, we invite you to join us on this transformative journey.
Why foraviset?
FORAVISET is not just developing treatments for women's health - we’re closing the innovation gap and reshaping the future of care. By pioneering Raviset®, a first-in-class, non-hormonal, non-surgical therapy, we are redefining how conditions like endometriosis are treated.
Raviset® targets the root cause of inflammation through the inducible Nitric Oxide Synthase (iNOS) pathway, offering a groundbreaking alternative to hormone-based and invasive solutions. With over two decades of research, compelling clinical outcomes, and a robust IP portfolio, Raviset® is designed to deliver safe, effective, and fertility-compatible relief.
We collaborate with leading hospitals, global regulatory experts, and patient communities to ensure our solutions meet rigorous scientific standards while being deeply human-centered. At Foraviset, we are building more than just medicine – we are creating a future where women's health can thrive without compromise.
